Waring Trible, MD
Gastroenterology · Bozeman, MTNPI 1043206238
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 276 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 40.2% of the total. Among gastroenterology clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 276 payments — averaging $17.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Takeda Pharmaceuticals U.S.A., Inc.$553
- Pfizer$426
- Johnson & Johnson$349
- Gilead$345
- Ipsen Biopharmaceuticals, Inc$156
- plus $1K from 16 others
What the payments were for
- Consulting fees$140%
- Food & beverage$4,839100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 131 | $1,951 |
| Takeda Pharmaceuticals U.S.A., Inc. | 34 | $553 |
| Pfizer | 19 | $426 |
| Johnson & Johnson | 17 | $349 |
| Gilead | 14 | $345 |
| Ipsen Biopharmaceuticals, Inc | 6 | $156 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $147 |
| Sanofi | 5 | $138 |
| Ironwood Pharmaceuticals, Inc | 6 | $99 |
| Bristol Myers Squibb | 6 | $97 |
| Madrigal Pharmaceuticals | 3 | $96 |
| Daiichi Sankyo Inc. | 4 | $85 |
| Phathom Pharmaceuticals, Inc. | 5 | $80 |
| Intercept Pharmaceuticals, Inc. | 4 | $67 |
| Merck | 3 | $51 |
| Ardelyx, Inc. | 3 | $47 |
| Evoke Pharma, Inc. | 3 | $46 |
| Ferring Pharmaceuticals Inc. | 2 | $34 |
| QOL Medical, LLC | 1 | $32 |
| Shire North American Group Inc | 1 | $21 |
| Enterra Medical, Inc. | 1 | $21 |
| Braintree Laboratories, Inc. | 1 | $13 |
How this compares
$4,853 in reported general payments places this provider in the 95th percentile of 34 gastroenterology providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mesalamine | 23 | $18,592 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 38 | $2,373 |
| CholestyramineCholestyramine (With Sugar) | 13 | $2,055 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 70 | $1,206 |
| Omeprazole | 63 | $1,033 |
| Pantoprazole Sodium | 92 | $948 |
| Esomeprazole Magnesium | 14 | $618 |
| Famotidine | 29 | $355 |
| Lansoprazole | 12 | $246 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Bozeman
- Andrew HermanBozeman$7K
- Michael LindnerBozeman$4K
- Andrew GentryBozeman$3K
- Kathryn LynchBozeman$3K
- Peter WalshBozeman$2K
- Nathaniel Spezia-LindnerBozeman$336
- Brian LandsverkBozeman$111
- Steven ShaneyfeltBozeman$38
- Juergen MuellerKalispell$4K
- Scott CooperMissoula$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.